Merck Sharp & Dohme Corp. - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Arqule Inc (ARQL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arqule Inc (ARQL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arqule Inc (ARQL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Merck Sharp & Dohme Corp. made no insider transaction in NGM Biopharmaceuticals Inc (NGM). Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 2,247,495 shares made by Column Group L P , a net purchase of 753,345 shares made by David V Goeddel , and a net sale of 85,082 shares made by Jin-long Chen .

In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 85,082 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 3,000,840 shares were bought by its insiders, resulting in a net purchase of 2,915,758 shares.

NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Merck Sharp & Dohme Corp. made no insider transaction in Sutro Biopharma Inc (STRO). Other recent insider transactions involving Sutro Biopharma Inc (STRO) include a net sale of 27,041 shares made by Brunilda Shtylla , and a net sale of 12,185 shares made by Nicki Vasquez .

In summary, during the past 3 months, insiders sold 0 shares of Sutro Biopharma Inc (STRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 39,226 shares of Sutro Biopharma Inc (STRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 39,226 shares.

Sutro Biopharma Inc (STRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Merck Sharp & Dohme Corp. made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 33,000 shares made by Patrick G Lepore , and a net purchase of 10,000 shares made by Mutya Harsch .

In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 43,000 shares were bought by its insiders, resulting in a net purchase of 43,000 shares.

VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of OpGen Inc (OPGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of OpGen Inc (OPGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

OpGen Inc (OPGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Merck Sharp & Dohme Corp. made no insider transaction in BeiGene Ltd (BGNE). Other recent insider transactions involving BeiGene Ltd (BGNE) include a net sale of 159,928 shares made by John Oyler , a net sale of 82,635 shares made by Xiaodong Wang , and a net sale of 13,539 shares made by Xiaobin Wu .

In summary, during the past 3 months, insiders sold 100,397 shares of BeiGene Ltd (BGNE) in total and bought 0 shares, with a net sale of 100,397 shares. During the past 18 months, 5,517,082 shares of BeiGene Ltd (BGNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,517,082 shares.

BeiGene Ltd (BGNE)'s detailed insider trading history can be found in Insider Trading Tracker table.